PDF | On May 1, , WERNER BUSTAMANTE E and others published Osteocondrodistrofía deformante (enfermedad de Morquio). PDF | REsuMEN La enfermedad de Morquio A o Mucopolisacaridosis IV A es un trastorno de depósito lisosomal pro-ducida por alteración en. Request PDF on ResearchGate | On Aug 1, , Juan Politei and others published Enfermedad de Morquio (mucopolisacaridosis IV-A): aspectos clínicos, .
|Published (Last):||9 April 2008|
|PDF File Size:||14.96 Mb|
|ePub File Size:||10.51 Mb|
|Price:||Free* [*Free Regsitration Required]|
Find out more about the cause, genetics, and impact of Morquio A.
VIMIZIM® (elosulfase alfa)
Whether you are newly diagnosed or have been living with Morquio A, here’s what you need to know about this rare condition: Key facts about causes, inheritance, and symptoms.
Endurance, and how it affects your heart, breathing, and muscles.
Disease progression, and how symptoms may change over time. Typical signs of anaphylaxis include cough, rash, throat tightness, hives, flushing, changes in skin color, low blood pressure, shortness of breath, chest pain, and gastrointestinal symptoms such as nausea, abdominal pain, retching, and vomiting.
If you have a respiratory illness, you may be at risk for a sudden worsening of your condition, and you may require additional monitoring. Tell your doctor if you are sick or taking any medication and if you are allergic to any medicines.
Also tell your doctor if you are pregnant, planning to become pregnant, or are a nursing mother. Anaphylaxis can occur during any VIMIZIM infusion morqui up to three hours after any infusion, and hypersensitivity reactions have been observed as early as 30 minutes from the start of infusion but as late as six days after infusion. Serious and severe reactions can happen with VIMIZIM treatment, including life-threatening allergic reactions anaphylaxishives, swelling, cough, shortness of breath, and flushing.
Contribución Colombiana al Conocimiento de la Enfermedad de Morquio A | Medicina
If a reaction occurs, the infusion should be slowed or stopped and you may be given additional medication. If a severe reaction occurs, the infusion should be stopped immediately and you will receive appropriate medical treatment.
If you have acute febrile or respiratory illness at the time of VIMIZIM infusion d may be at higher risk of life-threatening complications from hypersensitivity reactions. Signs of spinal cord injury include back pain, numbness and paralysis, and loss of bladder and bowel control.
Contact your doctor immediately if you develop any of these symptoms. The most common side effects reported during VIMIZIM infusions included fever, vomiting, headache, nausea, abdominal pain, chills, and fatigue.
Talk to your doctor if you enfermdead any symptoms that bother you or that do not go away.
Call your doctor for medical advice about side effects. You may report side effects to BioMarin Morqquio Inc. Please see full Prescribing Information, including important warning. The first and only enzyme replacement therapy approved for people with Morquio A. Join BioMarin for helpful Morquio A information, tools, and support. Have you been recently diagnosed with Morquio A?